a r t I C l e S Nicotinic AChRs mediate rapid excitatory synaptic transmission in the brain and periphery. An essential step toward understanding the mechanisms behind AChR-mediated excitation is determining AChR structure. X-ray crystal structures of the related AChBP revealed the overall fold of the extracellular domain of the subunits and positioning of subunits within the pentamer [1] [2] [3] . A cryo-electron microscopic structure of the Torpedo marmorata AChR disclosed the majority of the protein main chain and the approximate locations of residue side chains 4 . Further advances included X-ray crystal structures of the extracellular domain of the α 1 subunit from the muscle AChR bound to α-bungarotoxin 5 , and of prokaryotic orthologs [6] [7] [8] . These advances provided key insights into AChR structure, yet an essential goal that remains is an X-ray crystal structure of an AChR from a eukaryotic source.
Neuronal nicotinic α 7 AChRs are abundant in many brain regions 9 , notably in the hippocampus, where their pre-and postsynaptic locations 10 and high calcium permeability 11 suggest that they may contribute to learning and memory. α 7 AChRs exhibit distinctive pharmacology, with choline, a breakdown product of nerve-released acetylcholine (ACh), showing high efficacy 12 , contrary to its low efficacy at muscle AChRs 13 . α 7 AChRs have been implicated in neuropsychiatric 14 , neurodegenerative 15 and inflammatory 16 diseases, and thus are potential therapeutic targets for α 7 -selective agonists or antagonists that could be designed on the basis of X-ray crystal structural data.
The homopentameric composition of α 7 AChRs confers advantages for structural studies. Furthermore, because the ligand-binding sites localize at interfaces between extracellular regions of the subunits 17 , α 7 AChRs harbor five identical ligand-binding sites. Although the α 7 AChR and AChBP are homopentameric and share a similar structural fold, low sequence identity limits the use of AChBP structures for drug development and mechanistic studies.
For proteins that are difficult to express or crystallize, engineered protein modules provide valuable surrogates for structural analyses. A water-soluble α 7 ligand-binding domain was generated by truncating the protein chain before the first transmembrane domain, substituting the Cys-loop from AChBP and replacing hydrophobic with hydrophilic residues on the protein surface 18 . Here, we develop an analogous α 7 -AChBP chimera and determine X-ray crystal structures of the resulting pentamer and its complex with the agonist epibatidine. The findings provide the highest resolution images yet of an AChR ligand-binding pocket, including structures that mediate ligand recognition, signal transduction and interaction with inorganic cations. Comparison of the structures reveals molecular rearrangements triggered by the agonist, enabling structure-guided mutational studies of the native α 7 AChR. RESULTS a 7 -AChBP chimera construction and crystallographic analysis The α 7 AChR extracellular domain failed to produce folded protein when expressed in yeast, whereas AChBP yielded milligram amounts of correctly folded protein. We therefore generated a series of chimeras, combining sequences from α 7 with those from AChBP, aiming to maximize α 7 sequences within secondary structures and important loop regions ( Fig. 1 and Online Methods). The final construct shared 64% sequence identity and 71% similarity with native α 7 ( Supplementary  Fig. 1 ), was expressed in quantities similar to those of AChBP and The a 7 acetylcholine receptor (AChR) mediates pre-and postsynaptic neurotransmission in the central nervous system and is a potential therapeutic target in neurodegenerative, neuropsychiatric and inflammatory disorders. We determined the crystal structure of the extracellular domain of a receptor chimera constructed from the human a 7 AChR and Lymnaea stagnalis acetylcholine binding protein (AChBP), which shares 64% sequence identity and 71% similarity with native a 7 . We also determined the structure with bound epibatidine, a potent AChR agonist. Comparison of the structures revealed molecular rearrangements and interactions that mediate agonist recognition and early steps in signal transduction in a 7 AChRs. The structures further revealed a ring of negative charge within the central vestibule, poised to contribute to cation selectivity. Structure-guided mutational studies disclosed distinctive contributions to agonist recognition and signal transduction in a 7 AChRs. The structures provide a realistic template for structure-aided drug design and for defining structure-function relationships of a 7 AChRs. 1 2 5 4 VOLUME 14 | NUMBER 10 | OCTOBER 2011 nature neurOSCIenCe a r t I C l e S eluted as a sharp peak on size exclusion chromatography with a retention volume similar to that of AChBP. The α 7 -AChBP chimera bound radiolabeled α-bungarotoxin and epibatidine ( Supplementary Fig. 2 ), suggesting that it is a good model for the ligand-binding domain of the α 7 AChR.
We crystallized the α 7 -AChBP chimera in the absence of added ligands and in the presence of epibatidine, yielding Apo and Epi crystals, respectively. The Apo crystal diffracted to a resolution of 3.1 Å, and the Epi crystal diffracted to 2.8 Å. The higher resolution of the Epi crystal was probably due to stabilization by bound agonist. The Apo structure was solved by molecular replacement using AChBP (PDB code 1UW6) as the search model, and the Epi structure was solved using the Apo structure as the search model. The Apo and Epi crystals shared a similar packing arrangement, with the asymmetric unit containing two nearly identical pentamers, one of which we describe below. For both crystals, the electron density maps were improved by tenfold non-crystallographic symmetry (NCS) averaging, which overcame partial data completeness in the highest resolution shells. The electron density maps were of high quality ( Supplementary Figs. 3 and 4) , enabling structural and mechanistic analyses. Statistics of data collection and structure refinement are listed in Supplementary Table 1.
Overall structure
The Apo form of the α 7 -AChBP chimera has a canonical pentameric quaternary structure (Fig. 2a) , which superimposes well on that of AChBP (Fig. 2b) . Each monomer folds into a ten-stranded β-sandwich capped by an N-terminal α-helix ( Supplementary  Fig. 1b) , as in AChBP and Torpedo AChR. The β-sandwich core of the chimera subunit can be superimposed on those of mouse α1
and AChBP (Fig. 2c) , whereas the peripheral loops, α1-β1, β4-β5, β6-β7, and binding site loop F diverge, probably owing to sequence differences among the three proteins. The solvent-accessible surface consists of large and continuous regions of α 7 residues, including the ligand-binding site and structures that are implicated in signal transduction (Fig. 2d) , whereas the Cys loop and a stripe within the central vestibule contain AChBP residues.
The subunit interface contains residues from α 7 and AChBP, yet the interface structures of the chimera and AChBP are similar. However, notable differences between the two structures are evident in the upper and lower parts of the interface. In the upper part, interactions between the α1-β1 loop from the principal face and the α1 helix and β2-β3 loop from the complementary face differ, probably owing to a buried hydrogen bond between Tyr14 and Asp60, conserved in AChRs but absent in AChBP, that links the α1-β1 and β2-β3 loops within each subunit (Supplementary Fig. 5 ). In the lower part, the β1-β2 loop from one subunit and loop F from the adjacent subunit show a local shift, probably owing to sequence differences (Supplementary Fig. 6 ). The Epi structure mirrors the Apo structure, except for the ligand-binding pocket and flanking regions (Fig. 2e) . All ten binding sites in the asymmetric unit show electron density corresponding to an epibatidine molecule. Thus, in terms of the structural fold, surface properties and Fig. 7 ). In muscle AChR, signal transduction is mediated by residues equivalent to Tyr184 from β-strand 9, Asp193 from β-strand 10 and Lys141 from β-strand 7 (ref. 19) , which extend to the pore, enabling intra-subunit communication.
Regions that flank the ligand-binding core contain several α 7 -specific residues of potential functional importance. These residues disperse around loop C, which changes conformation upon agonist binding 2, 3 and initiates early steps in signal transduction 19, 20 . Located in sub-regions I-IV (Fig. 3a) , these α 7 -specific residues comprise Arg182 from loop C, which approaches Tyr184 and Lys141 of the same subunit ( Fig. 3b and Supplementary Fig. 3a) ; Arg179 from loop C, which interacts with Asp153 from the β8-β9 loop and Glu181 from loop C of the same subunit (Fig. 3c) ; Glu185 from loop C, which approaches Glu158 and Asp160 from loop F of the complementary subunit (Fig. 3d,e) ; and a glycan from Asn108 of the complementary subunit that makes van der Waals contact with loop C of the principal subunit (Fig. 3f) .
The Apo crystal showed a strong density at the center of the ligandbinding pocket (Supplementary Fig. 8 ). The chemical identity of this density is unknown, but its position overlapped with the quaternary ammonium moiety of carbamylcholine bound to AChBP (PDB 1UV6) and the alicyclic moiety of epibatidine in the Epi crystal.
Ligand-induced changes
Superposition of the Apo and Epi structures reveals changes in the ligand-binding pocket and surrounding regions (Fig. 2e) , and these changes propagate to distal parts of the subunits and subunit interfaces (Fig. 4a) . The most substantial change occurs in loop C, which in the Apo structure adopts a range of opened-up conformations among the different subunits (Fig. 4b) . By contrast, in the Epi structure, loop C assumes a closed-in conformation in all ten subunits of the asymmetric unit. Given the conformational dynamics of loop C, NCS averaging was not applied to this region. Nevertheless, in the Apo and Epi structures, electron density for loop C is well defined (Supplementary Figs. 3a and 4a) .
Smaller shifts are observed in loops α1-β1, A, B and F, and in β-strands 7, 9 and 10. These shifts comprise a concerted rotation of the outer β-sheet in a clockwise direction when viewed down an axis through the pentamer, while loops α1-β1, B and C rotate counterclockwise (Fig. 4a) , altering the pentamer interface in this region (Supplementary Fig. 9 ). The rotation and twist of the outer sheet is accompanied by inward bending of the β-barrel, causing repacking of the β-sandwich core such that Phe196 switches between distinct rotamer positions (Fig. 4a,c) ; phenylalanine or tyrosine is present at the position equivalent to Phe196 in all AChR α-subunits. The concerted nature of these shifts suggests that they are not artifacts of limited resolution, which would produce random shifts. Moreover, the large change of Phe196 is clear at the current resolution (Fig. 4c) . By contrast, the inner β-sheet remains stationary between the two structures (Fig. 4a) .
Epibatidine-induced changes in loops A, B, C and F are accompanied by reorganization of residues within the ligand-binding pocket (Fig. 5a) . The most substantial changes are shifts of Tyr184 of loop C and Tyr91 of loop A, which frame the tertiary nitrogen of epibatidine against Trp145 from loop B. These primary stabilizing residues are augmented by Tyr191 from loop C and Trp53 from loop D, with Trp53 exhibiting multiple conformations in the Apo structure but only one conformation in the Epi structure. The positioning of the five conserved aromatic residues is similar to that noted for AChBP with bound epibatidine at 3.4 Å resolution 3 (Supplementary Fig. 7 ), but the 2.8 Å resolution of our Epi structure defines orientations of backbone carbonyls and aromatic side chains in a binding site containing solely α 7 residues.
In parallel with changes in the conserved aromatic residues, residues that are implicated in signal transduction rearrange and show previously unobserved interactions with ligand recognition residues (Fig. 5b) . In the Apo structure, the Lys141 side chain is only partially defined by the electron density, suggesting dynamic motions or contacts among multiple partners. However, in the Epi structure the Lys141 side chain is defined, revealing a hydrogen bond between its ε-amino moiety and the aromatic hydroxyl of Tyr184 from loop C, and also a π-cation interaction with Tyr91 from loop A as it contacts a r t I C l e S epibatidine ( Fig. 5c and Supplementary Fig. 10 ). Furthermore, in the Apo structure, Arg182 exhibits two conformations, stacking against the aromatic ring of Tyr184 or extending toward Lys141 (Fig. 3b and Supplementary Fig. 3a) , but in the Epi structure, Arg182 stacks uniformly against Tyr184 while simultaneously hydrogen bonding to the main-chain carbonyl of Phe183 and linking to Lys141 through a solvent molecule-most probably water ( Fig. 5c and Supplementary  Fig. 10 ). Thus, in the Apo structure, Tyr184, Tyr91, Lys141 and Arg182 disperse loosely within the binding site, but in the Epi structure they converge into an ordered assembly. Association of Lys141 with Tyr184 and Tyr91 was noted in the X-ray crystal structure of AChBP with bound nicotine 2 , but not in that of AChBP with bound epibatidine 3 . With the addition of Arg182, our Epi structure reveals an ordered assembly of aromatic and cationic residues linking bound agonist to loop C, loop A and the base of the Cys-loop (Fig. 5c) . Additional α 7 -specific residues that are associated with loop C may also be functionally important. In the Apo structure, Glu185 projects from the tip of loop C toward Glu158 and Asp160 from loop F of the opposing subunit, creating a region of negative electrostatic potential (Fig. 3e) , while the glycan linked to Asn108 of the complementary subunit makes van der Waals contact with the disulfide bond between Cys186 and Cys187 from loop C of the principal subunit (Fig. 3f) . In the Epi structure, the glycan dissociates from loop C as this loop clamps down on epibatidine (Fig. 5d) , and loop F moves away from loop C, perhaps aided by repulsion between Glu185 and Glu158. In the Apo structure, the combination of a negative electrostatic potential and hydrophilic glycan may create an environment that facilitates the association of the cationic ACh or inorganic ion modulators such as calcium.
At the base of loop C, additional α 7 -specific residues anchor loop C to loop F of the same subunit. In the Apo structure, Arg179 establishes electrostatic interaction with neighboring Glu181 and Asp153 from loop F, and it also hydrogen bonds to Gln155 from loop F (Fig. 3c) . Asp153, in turn, hydrogen bonds to Thr28 from β-strand 1, while the aliphatic portion of Gln155 makes van der Waals contact with Tyr30. Van der Waals contacts also form between Met156 from loop F and main-chain atoms of Lys178 and Arg179. This network of surface-exposed residues, present in all subunits, is particularly well defined by the electron density maps. Positioned at the base of loop C, this stable network may act as a fulcrum against which loop C flexes. Indeed, in the higher resolution Epi structure, this network is maintained (Supplementary Fig. 11 ).
Epibatidine recognition and inter-subunit contacts
The azabicyclo moiety of epibatidine lodges in the center of the aromatic cage (Fig. 6) . Stabilizing interactions comprise a π-cation interaction between the bridging amino group of epibatidine and the indole ring of Trp145, and hydrogen bonds between the bridging amino group and the main-chain carbonyl of Trp145 and the hydroxyl of Tyr91. These are augmented by extensive van der Waals contacts between the aliphatic portion of the azabicyclo moiety and Tyr184, 
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Cys186, Cys187 and Trp145, and an interaction between the aromatic ring of Tyr191 and one of the two electropositive carbon atoms vicinal to the bridging amino group in epibatidine. The chloropyridine ring stacks edge-to-face against the indole ring of Trp145 and makes van der Waals contact with Thr146. At the complementary face of the binding site, the chlorine atom of epibatidine lodges close to the mainchain carbonyl groups of Gln114 (2.7 Å) and Leu104 (3.3 Å); the distances and geometry observed here concur with known halogen bonds, suggesting an unusual role in stabilizing epibatidine 21 . The chloropyridine ring also makes van der Waals contacts with Leu104, Leu106 and Gln114. Trp53 at the complementary face does not contact epibatidine directly, but stacks edge-to-face against Trp145, stabilizing that side chain. Comparing our Epi structure with AChBP bound to epibatidine 3 reveals a similar mode of ligand recognition mediated by a similar principal face but a divergent complementary face. In native AChR, the ligand-binding domain establishes a major communication link with the pore domain 22, 23 . In the present structures this linkage region exhibits previously unobserved inter-subunit interactions. The β1-β2 loops from adjacent subunits align in a head-to-tail manner, unlike in AChBP, in which successive β1-β2 loops make little contact (Fig. 7a) . Lys44 from the tip of the β1-β2 loop of the principal subunit establishes electrostatic interaction with Asp40 from the tail of the β1-β2 loop of the complementary subunit, and Asn45 of the principal subunit hydrogen bonds with the main-chain carbonyl of Met39 of the complementary subunit. Asn45 is conserved among AChR α-subunits, but Lys44 and Asp40 are specific to certain neuronal AChRs (Fig. 1) . Inter-subunit contacts that are mediated by the β1-β2 loops are augmented by interactions between β-strand 6 from the principal subunit and loops β1-β2 and F from the complementary subunit (Fig. 7b) . For example, Ser124 in β-strand 6 of the principal subunit makes van der Waals contact with Ile165 in loop F and hydrogen bonds with Gln37 in the β1-β2 loop of the complementary subunit. In muscle AChR, residues that are equivalent to Ser124 and Gln37 mediate inter-subunit communication essential for efficient channel gating 24 . Moreover, the tandem arrangement of the β1-β2 loops creates a ring of ten aspartate and five asparagine residues that produces a strong negative surface potential facing the central vestibule, which in native α 7 AChRs may concentrate sodium and calcium ions for permeation.
Mutational analyses
The Epi structure suggested that primarily three residues from the principal face of the binding site stabilized epibatidine: Trp145 from loop B, Tyr184 from loop C and Tyr91 from loop A. To test this interpretation, we substituted phenylalanine for each of the five conserved aromatic residues in the α 7 AChR binding site and measured epibatidine binding. Under steady-state conditions, epibatidine bound to the α 7 AChR cooperatively and with high affinity (Fig. 8a) . Substituting phenylalanine at any of the four positions at the principal face maintained cooperativity, whereas substituting at Trp53 at the complementary face markedly reduced cooperativity. Furthermore, phenylalanine substitutions increased the apparent dissociation constant by 4-to 2,200-fold, with the rank order Trp145 > Tyr184 > Tyr91 > Tyr191 > Trp53. Substitution at Trp145 reduces the size of the aromatic ring, which would weaken the π-cation interaction with the bridging nitrogen and the edge-to-face stacking with the chloropyridine ring on epibatidine, whereas substitution at Tyr91 would remove the hydrogen bond to the bridging nitrogen. Substitution at Tyr184 would remove the hydrogen bond to Lys141, impairing the closure of loop C and consequently weakening the π-cation interaction between Lys141 and Tyr91. Substitutions at Tyr191 and Trp53, however, decreased affinity to smaller extents. Thus, results from mutagenesis in α 7 are fully consistent with the model of epibatidine binding that is provided by our structure.
Measurements of steady-state agonist binding can also indicate changes in signal transduction. We therefore examined the binding of ACh to α 7 AChRs containing mutations of α 7 -specific residues that were highlighted in the structures. Substitutions at Arg182, Glu185 and Glu181, all in loop C (Fig. 3) , increased affinity of the agonist for the α 7 AChR (Fig. 8b) . Substitution at Gln37, which spans the a r t I C l e S subunit interface (Fig. 7b) , also increased affinity. Because ACh binding is highly cooperative, the observed increases in affinity show that agonist concentrations that minimally occupy native α 7 fully occupy the mutants. Steady-state agonist binding provides a global measure of AChR function, encompassing equilibria among resting, active and desensitized states and their associated affinities. Thus, these α 7 -specific residues that are highlighted in the structures are likely to contribute to signal transduction steps linked to agonist binding.
DISCUSSION
Here we present X-ray crystal structures of a chimeric ligandbinding domain of the α 7 AChR in apo and agonist-bound conformations. Because the ligand-binding site and flanking regions consist entirely of α 7 residues, the structures provide the highest resolution images that have so far been obtained of the AChR in regions that govern ligand recognition and the initial steps in signal transduction. Furthermore, the structures provide realistic templates for computational drug design, as well as bases for probing structure-function relationships of the physiologically and clinically important neuronal α 7 AChR. The structures also resolve residues that emerge as candidates to confer α 7 -specific functional properties. Among these, residues in loop C that do not contact bound agonist contribute to the inherently low agonist affinity of the α 7 AChR, suggesting that they affect transduction of agonist binding to channel gating or desensitization.
Within the ligand-binding cleft, conserved aromatic and α 7 -specific residues stem from multiple canonical loops that form the ligand contact surface. Trp145 is the main stabilizing residue, as is evident from π-cation and dipole-cation interactions with the bridging nitrogen of epibatidine, and it exhibits the largest decrease in affinity on mutation. Trp145 shows little change between Apo-and Epi structures and thus is a stationary receiver to which agonist is directed by centric shifts of Tyr184 and Tyr91. The hydroxyl of Tyr91 from loop A directly stabilizes the bridging nitrogen on epibatidine, whereas the hydroxyl of Tyr184 provides little direct stabilization but stabilizes loop C in the closed-in conformation through interaction with Lys141 stemming from the base of the Cys-loop. Tyr91 and Tyr184 are further stabilized by π-cation interactions with Lys141 and Arg182, respectively. The convergence of these residues toward bound epibatidine creates an ordered assembly of cationic and aromatic side chains that locks loops A and C into positions that sequester the agonist.
Substituting phenylalanine for any of the five conserved aromatic residues reduced epibatidine affinity for the α 7 AChR, in accord with interactions that are seen in the bound complex. However, steady-state agonist binding is a composite measure, encompassing intrinsic affinity and signal transduction steps that are associated with resting, open channel and desensitized states. For example, in muscle AChR, substituting phenylalanine for the residue equivalent to Tyr184 decreases both agonist affinity and channel gating efficacy 20 . Analogously, in α 7 , substituting phenylalanine for Tyr91 decreased affinity through loss of direct interaction with agonist, but it may also affect signal transduction through a change of the π-cation interaction with Lys141. Thus, although aromatic residues that contact agonist are clear in the Epi structure, their functional contributions are likely to encompass both agonist recognition and signal transduction.
Residues within the binding cleft unique to α 7 emerge as candidates to confer type-specific ligand recognition properties. At the principal face, the Pro190-Tyr191-Pro192 sequence in loop C, unique to α 7 , α 9 and α 10 , may affect interaction of Tyr191 with the agonist. At the complementary face, the ascending and descending β-strands of loop E offer a pair of main-chain carbonyl groups that engage in halogen bonding to the chlorine atom on epibatidine. This second anchor positions the chloropyridine ring to establish van der Waals contacts with loop E residues specific to α 7 : Leu106, Leu116 and Glu114. Thus, toward computational drug design, our Epi structure provides the best available template because the binding site derives entirely from α 7 and the resolution is 2.8 Å.
Comparison of the Apo and Epi structures reveals changes within the ligand-binding pocket and flanking regions, highlighting the concept that ligand recognition not only draws together residues to stabilize agonist but also recruits residues to mediate signal transduction. These local changes propagate to the rest of protein, leading to twisting, inward bending and repacking of the β-sandwich core of the subunit and the switching of Phe196 between distinct rotamer positions (Fig. 4a) . The functional importance of these structural changes requires further study, but the present findings demonstrate that local changes due to agonist binding affect distal sites within the subunit and the pentamer.
Three α 7 -specific residues in loop C-Arg182, Glu185 and Glu181-do not contact agonist but contribute to low affinity of the α 7 AChR. Mutation of any of these residues shifts steady-state ACh binding to lower concentrations; because agonist binding is cooperative, agonist concentrations that minimally occupy native α 7 fully occupy the mutant AChRs. Mechanistically, these residues may affect one or a combination of processes, including agonist affinity for resting, active or desensitized states, or transitions among these states. Arg182 and Glu185, located underneath loop C, juxtapose residues with the same charge, with Arg182 pairing with Lys141 and Glu185 pairing with Glu158 and Asp160. The increased affinity produced by the mutants R182V and E185Q may thus arise from relief of electrostatic repulsion, which in native α 7 may favor the opened-up conformation of loop C, contributing to low agonist affinity. On the other side of loop C, Glu181 is part of a network encompassing Arg179, Asp 153 and Gln155, anchoring loop C to loop F. In native α 7 , this network may promote low agonist affinity, as disrupting it with the mutation E181S increases affinity. Thus, by revealing inter-residue interactions of α 7 -specific residues, the present structures provide insights into the unique functional properties of α 7 AChRs.
The structures exhibit a tandem arrangement of β1-β2 loops that creates a ring of ten aspartate and five asparagine residues facing the central vestibule that may concentrate cations before translocation. This arrangement arises through extensive inter-subunit contacts, comprising van der Waals, hydrogen bonding and electrostatic forces between successive β1-β2 loops and between β4-β5 and Cys loops of one subunit and loop F of the opposing subunit. In muscle AChR, simulations of single-cation translocation showed discrete pauses of the a r t I C l e S cation, one of which coincided with the ring identified here 25 . However, in muscle AChR, the ring contains five fewer Asp residues, perhaps contributing to its lower unitary conductance and reduced calcium permeability. In the recent structure of a glutamate-activated chloride channel from the Cys-loop superfamily 26 , this ring is neutral, containing lysine, aspartate and asparagine at equivalent positions, in line with its anion selectivity. Thus, the present findings not only define structures conserved among AChRs but also structures unique to α 7 .
METhODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureneuroscience/.
Accession codes. RCSB Protein database: atomic coordinates and structure factors have been deposited with accession codes 3SQ9 (Apo) and 3SQ6 (Epi).
Note: Supplementary information is available on the Nature Neuroscience website.
